vincristine
Showing 1 - 25 of 320
Pediatric Cancer Trial in Eldoret (Vincristine)
Recruiting
- Pediatric Cancer
- Vincristine
-
Eldoret, Rift Valley, KenyaMoi Teaching and Referral Hospital
Apr 25, 2023
Sarcoma, Ewing, Rhabdomyosarcoma Trial run by the National Cancer Institute (NCI) (PEN-866, Vincristine, Temozolomide)
Not yet recruiting
- Sarcoma, Ewing
- Rhabdomyosarcoma
- PEN-866
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Ewing Sarcoma Trial in Beijing (Vincristine, Temozolomide)
Recruiting
- Ewing Sarcoma
- Vincristine
- Temozolomide
-
Beijing, Beijing, ChinaPeking University People's Hospital
Oct 31, 2022
Optic Glioma, Pediatric Brain Tumor, Optic Nerve Glioma Trial in Beijing (Carboplatin, Vincristine, Recombinant human
Recruiting
- Optic Glioma
- Pediatric Brain Tumor, Optic Nerve Glioma
- Carboplatin
- +2 more
-
Beijing, ChinaCapital Medical University Sanbo Brain Hospital
Jul 4, 2022
Solid Tumors, Primary Brain Tumors Trial in United States (Vincristine, Irinotecan, Temozolomide)
Completed
- Solid Tumors
- Primary Brain Tumors
- Vincristine
- +3 more
-
Hartford, Connecticut
- +13 more
Jan 12, 2023
Neuroblastoma, Pediatric Cancer Trial in New York (Cyclophosphamide, Topotecan, Vincristine)
Recruiting
- Neuroblastoma
- Pediatric Cancer
- Cyclophosphamide
- +7 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 11, 2023
Large B-cell Lymphoma Trial in Houston (Prednisone, Rituximab, Cyclophosphamide)
Not yet recruiting
- Large B-cell Lymphoma
- Prednisone
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 19, 2023
Solid Tumor Trial in Dallas (Atezolizumab, Vincristine, Irinotecan)
Not yet recruiting
- Solid Tumor
- Atezolizumab
- +3 more
-
Dallas, TexasThe University of Texas Southwestern Medical Center
Aug 30, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial (Biospecimen Collection, Vincristine)
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Biospecimen Collection
- Vincristine
-
Birmingham, Alabama
- +20 more
Jan 23, 2023
Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage Trial in Houston (Clofarabine,
Recruiting
- Acute Bilineal Leukemia
- +7 more
- Clofarabine
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)
Recruiting
- Myelodysplastic Syndromes, de Novo
- +10 more
- Venetoclax
- +10 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 23, 2023
Rhabdomyosarcoma Trial in Palo Alto, Memphis, Fort Worth (Vincristine, Dactinomycin, Cyclophosphamide)
Not yet recruiting
- Rhabdomyosarcoma
- Vincristine
- +8 more
-
Palo Alto, California
- +2 more
Aug 27, 2023
Diffuse Large B Cell Lymphoma, DLBCL, Cancer Trial in Madison (Rituximab, Cyclophosphamide, Doxorubicin)
Recruiting
- Diffuse Large B Cell Lymphoma
- +2 more
- Rituximab
- +5 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Dec 12, 2022
Obinutuzumab-based Therapy for Previously Untreated FL
Recruiting
- Follicular Lymphoma
- Obinutuzumab
- +6 more
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University School of Medicin
Jun 3, 2023
High-risk Large B-cell Lymphoma (LBCL) Trial (Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine)
Not yet recruiting
- High-risk Large B-cell Lymphoma (LBCL)
- Axicabtagene Ciloleucel
- +7 more
- (no location specified)
Dec 13, 2022
DLBCL Trial in Cleveland (Loncastuximab tesirine, Prednisone, Rituximab)
Withdrawn
- Diffuse Large B-Cell Lymphoma
- Loncastuximab tesirine
- +5 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center
Mar 15, 2022
Diffuse Large B Cell Lymphoma Trial (Rituximab, Cyclophosphamide, Doxorubicin)
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- Rituximab
- +7 more
- (no location specified)
Apr 24, 2022
Peripheral T-cell Lymphoma Targeted Therapy Trial in Tianjin (Azacitidine, Chidamide, Cyclophosphamide)
Enrolling by invitation
- Peripheral T-cell Lymphoma Targeted Therapy
- Azacitidine
- +5 more
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Insititute & Hospital
Jan 9, 2023
Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Memphis (drug, biological, radiation)
Not yet recruiting
- Refractory Acute Lymphoblastic Leukemia
- Relapsed Acute Lymphoblastic Leukemia
- Venetoclax
- +16 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 23, 2022
Diffuse Large B Cell Lymphoma Trial in Shenyang (Zanubrutinib, Rituximab, Cyclophosphamide)
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- Zanubrutinib
- +5 more
-
Shenyang, Liaoning, ChinaXing Xiaojing
Jun 1, 2023
DLBCL Germinal Center B-Cell Type Trial in China (Selinexor, Rituximab, Cyclophosphamide)
Recruiting
- DLBCL Germinal Center B-Cell Type
- Selinexor
- +5 more
-
Guangzhou, Guangdong, China
- +5 more
Aug 16, 2022
Leukemia Trial in Houston (Cyclophosphamide, Vincristine, Blinatumomab)
Not yet recruiting
- Leukemia
- Cyclophosphamide
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Dec 23, 2022